InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures
Go back to InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures| INSPIREMD, Inc. (NASDAQ: NSPR) | Delayed: 0.72 +0.01 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.71 | 52 Week High | $3.35 | |||
| Open | $0.72 | 52 Week Low | $0.07 | |||
| Day High | $0.77 | P/E | N/A | |||
| Day Low | $0.72 | EPS | $-0.96 | |||
| Volume | 96,070 | |||||
